- Industry wants more clarity on NGS for assessing gene therapy safety<p>The pharmaceutical industry has largely endorsed the US Food and Drug Administration's (FDA) guidance on next-generation sequencing (NGS) for assessing the safety of human gene therapy products.…raps · 10d ago↗ source
- This Week at FDA: FDA staff raise concerns about peptide conflicts, top Democrat wants DOGE investigation, and more<p>Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This…raps · 10d ago↗ source
- Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics<figure><div><img src="https://imgproxy.divecdn.com/tzaRDX3CbhReY4UgPVj2iCgN5MzQ9V_AQf0Jo1lvCvY/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy05OTEzMjk1ODQuanBn.…